Girija Dasmahapatra

Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation.

Sudhir B. Kondapaka, Sheo S. Singh, Girija Dasmahapatra et al. · PubMed · 2003 · 405 citations

Cancer Research, Signal Transduction, Chemoprevention Strategy +15

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo

Girija Dasmahapatra, Dmitry Lembersky, Lora B. Kramer et al. · Blood · 2010 · 106 citations · Full text

The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism

Girija Dasmahapatra, Mohamed Rahmani, Paul Dent et al. · Blood · 2005 · 94 citations · Full text

The Bruton tyrosine kinase (<scp>BTK</scp>) inhibitor <scp>PCI</scp>‐32765 synergistically increases proteasome inhibitor activity in diffuse large‐B cell lymphoma (<scp>DLBCL</scp>) and mantle cell lymphoma (<scp>MCL</scp>) cells sensitive or resistant to bortezomib

Girija Dasmahapatra, Hiral Patel, Paul Dent et al. · British Journal of Haematology · 2013 · 84 citations · Full text

Mechanism by Which Mcl-1 Regulates Cancer-Specific Apoptosis Triggered by mda-7/IL-24, an IL-10–Related Cytokine

Rupesh Dash, Joanna E. Richards, Zhao-zhong Su et al. · Cancer Research · 2010 · 71 citations